Introduction to Biologic and Biosimilar Product Development and Analysis (eBook)
XI, 109 Seiten
Springer International Publishing (Verlag)
978-3-319-98428-5 (ISBN)
Karen Nagel is an Associate Professor of Pharmaceutics at Midwestern University Chicago College of Pharmacy where she has worked since 1999. She received her Ph.D in Industrial and Physical Pharmacy from Purdue University. Her current teaching responsibilities include required and elective courses in compounding, dosage form design, biotechnology, and the history of pharmacy. In order to increase their knowledge of and interest in careers in academia, she precepts several academic APPE rotation students per year.
Dr. Nagel's primary areas of research are herbal product analysis and pharmaceutical compounding. She also has interests in biotechnology, dosage form design and educational research, and has contributed to several textbooks, review guides and encyclopedias.
Dr. Nagel has been a member of AAPS since 1994 and has served on the planning committee of the local chapter, the Chicagoland Pharmaceutics Discussion Group, since 2002 (Treasurer, 2002-04; Chair, 2005-06). Dr. Nagel is a past chair (2010-11) of the APhA APRS Basic Sciences section, and has served on the APRS Awards, Education, and Policy committees. She has also been a member of AACP since 1999, serving as secretary of the Teachers of Pharmaceutics section (TOPS) from 2005-7 and as chair of the Laboratory SIG from 2004-5. She has served as an abstract and grant reviewer for AACP and APhA, and has moderated sessions at annual meetings for both groups. She also has served on the NABP Foreign Pharmacy Equivalency Exam Review Committee since 2003. Dr. Nagel serves on numerous college and university committees and is faculty advisor to the Midwestern University AAPS Student Chapter.Karen Nagel is an Associate Professor of Pharmaceutics at Midwestern University Chicago College of Pharmacy where she has worked since 1999. She received her Ph.D in Industrial and Physical Pharmacy from Purdue University. Her current teaching responsibilities include required and elective courses in compounding, dosage form design, biotechnology, and the history of pharmacy. In order to increase their knowledge of and interest in careers in academia, she precepts several academic APPE rotation students per year. Dr. Nagel’s primary areas of research are herbal product analysis and pharmaceutical compounding. She also has interests in biotechnology, dosage form design and educational research, and has contributed to several textbooks, review guides and encyclopedias. Dr. Nagel has been a member of AAPS since 1994 and has served on the planning committee of the local chapter, the Chicagoland Pharmaceutics Discussion Group, since 2002 (Treasurer, 2002-04; Chair, 2005-06). Dr. Nagel is a past chair (2010-11) of the APhA APRS Basic Sciences section, and has served on the APRS Awards, Education, and Policy committees. She has also been a member of AACP since 1999, serving as secretary of the Teachers of Pharmaceutics section (TOPS) from 2005-7 and as chair of the Laboratory SIG from 2004-5. She has served as an abstract and grant reviewer for AACP and APhA, and has moderated sessions at annual meetings for both groups. She also has served on the NABP Foreign Pharmacy Equivalency Exam Review Committee since 2003. Dr. Nagel serves on numerous college and university committees and is faculty advisor to the Midwestern University AAPS Student Chapter.
1. Principles of Recombinant DNA Technologya. Introductionb. Production methodsc. Purification technologyd. Characterizatione. Analysis and regulationf. Summary points2. Therapeutic Proteinsa. Introduction: Protein/peptide structure and what that means for deliveryb. Delivery challengesc. Potential methods of deliveryd. Summary points3. Therapeutic Antibodiesa. Drug development and antibody engineeringb. Pharmacokinetics of monoclonal antibodiesc. Delivery methodsd. Clinical applicationse. Antibody-specific adverse effectsf. Therapeutic areasg. Summary points4. Analysis and Regulation of Biologics, Including Biosimilarsa. Introductionb. FD&C Act Section 505(b)(2) and the products that currently may be approved via this pathwayc. PHS Act / Biologics Price Competition and Innovation (BCPI) Act of 2009d. Summary Points
| Erscheint lt. Verlag | 27.9.2018 |
|---|---|
| Reihe/Serie | AAPS Introductions in the Pharmaceutical Sciences | AAPS Introductions in the Pharmaceutical Sciences |
| Zusatzinfo | XI, 109 p. 4 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Themenwelt | Naturwissenschaften ► Chemie |
| Technik | |
| Schlagworte | Biologics analysis • biologics regualtion • Recombinant DNA technology • Therapeutic Antibodies • Therapeutic proteins |
| ISBN-10 | 3-319-98428-4 / 3319984284 |
| ISBN-13 | 978-3-319-98428-5 / 9783319984285 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 1,6 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
